Mem Inst Oswaldo Cruz, Rio de Janeiro, 112(8) August 2017
Original Article

Biosynthesized silver nanoparticles: are they effective antimicrobials?

Mudara K Peiris1, Chinthika P Gunasekara1, Pradeep M Jayaweera2, Nuwan DH Arachchi2, Neluka Fernando1/+

1University of Sri Jayewardenepura, Faculty of Medical Sciences, Department of Microbiology, Gangodawila, Nugegoda, Sri Lanka
2University of Sri Jayewardenepura, Faculty of Applied Sciences, Department of Chemistry, Gangodawila, Nugegoda, Sri Lanka

Page: 537-543 DOI: 10.1590/0074-02760170023
427 views 419 downloads
ABSTRACT

BACKGROUND Silver nanoparticles (AgNPs) are increasingly being used in medical applications. Therefore, cost effective and green methods for generating AgNPs are required.

OBJECTIVES This study aimed towards the biosynthesis, characterisation, and determination of antimicrobial activity of AgNPs produced using Pseudomonas aeruginosa ATCC 27853.

METHODS Culture conditions (AgNO3 concentration, pH, and incubation temperature and time) were optimized to achieve maximum AgNP production. The characterisation of AgNPs and their stability were evaluated by UV-visible spectrophotometry and scanning electron microscopy.

FINDINGS The characteristic UV-visible absorbance peak was observed in the 420u2013430 nm range. Most of the particles were spherical in shape within a size range of 33u2013300 nm. The biosynthesized AgNPs exhibited higher stability than that exhibited by chemically synthesized AgNPs in the presence of electrolytes. The biosynthesized AgNPs exhibited antimicrobial activity against Escherichia coli, P. aeruginosa, Salmonella typhimurium, Staphylococcus aureus, methicillin-resistant S. aureus, Acinetobacter baumannii, and Candida albicans.

MAIN CONCLUSION As compared to the tested Gram-negative bacteria, Gram-positive bacteria required higher contact time to achieve 100% reduction of colony forming units when treated with biosynthesized AgNPs produced using P. aeruginosa.

Financial support: University of Sri Jayewardenepura (ASP/01/RE/MED/2016/42)
+ Corresponding author: fneluka@sjp.ac.lk
Received 20 January 2017
Accepted 23 March 2017

Our Location

Memórias do Instituto Oswaldo Cruz

Av. Brasil 4365, Castelo Mourisco 
sala 201, Manguinhos, 21040-900 
Rio de Janeiro, RJ, Brazil

Tel.: +55-21-2562-1222

This email address is being protected from spambots. You need JavaScript enabled to view it.

Support Program

logo fiocruz logo governo
logo faperj logo cnpq marca capes